MT Newswires9d agoneutral
Goldman Sachs Adjusts Price Target on Bristol-Myers Squibb to $61 From $63Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
24/7 Wall St.76d agoneutral
Pfizer Stock: Wall Street Sees a Rebound, Here’s Our Price TargetStockStory100d agobullish
BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook